Breaking

BofA's Countrywide Is Ordered to Pay $1.3B for Defective Loans
Tweet TWEET

Galena Biopharma to Present at the Piper Jaffray 24th Annual Healthcare Conference

Galena Biopharma to Present at the Piper Jaffray 24th Annual Healthcare
Conference

LAKE OSWEGO, Ore., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc.
(Nasdaq:GALE), a biotechnology company focused on developing innovative,
targeted oncology treatments that address major unmet medical needs to advance
cancer care, today announced that Mark J. Ahn, Ph.D., President and CEO, will
present a corporate overview at the Piper Jaffray 24^th Annual Healthcare
Conference. The presentation will take place on Tuesday, November 27, 2012 at
2:30 p.m. EST at The New York Palace Hotel in New York, NY.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company that develops innovative, targeted oncology
treatments that address major unmet medical needs to advance cancer care. For
more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10647

CONTACT: Madeline Hatton
         Toll free: +1 (855) 855-GALE (4253), ext. 109
         info@galenabiopharma.com
        
         or
        
         Remy Bernarda
         IR Sense, LLC
         +1 (503) 400-6995
         remy@irsense.com

Galena Biopharma, Inc.